Drugs to reverse Alzheimer's disease prove elusive

Recent clinical trials aimed at halting Alzheimer's have faltered and such treatment appears to be far off. Even so, much has been uncovered about the devastating disease. On Tuesday, someone from the biotech company Myriad Genetics Inc. will stand before hundreds of sober-faced scientists in a conference room in Chicago and try to explain why yet another highly anticipated medication for Alzheimer's disease will not make it to the marketplace.

Read the whole article on LA Times - Health

More from LA Times - Health